Anika Therapeutics (ANIK) shoots up 7.3% premarket after the firm record a 25% Y/Y increase in...

|About: Anika Therapeutics Inc. (ANIK)|By:, SA News Editor

Anika Therapeutics (ANIK) shoots up 7.3% premarket after the firm record a 25% Y/Y increase in Q4 revenue and shows a profit. The company says growth was primarily led by strong domestic and international sales of Orthovisc.